pubmed-article:11742003 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11742003 | lifeskim:mentions | umls-concept:C1859521 | lld:lifeskim |
pubmed-article:11742003 | lifeskim:mentions | umls-concept:C1720416 | lld:lifeskim |
pubmed-article:11742003 | lifeskim:mentions | umls-concept:C0205245 | lld:lifeskim |
pubmed-article:11742003 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:11742003 | lifeskim:mentions | umls-concept:C1456413 | lld:lifeskim |
pubmed-article:11742003 | lifeskim:mentions | umls-concept:C0599155 | lld:lifeskim |
pubmed-article:11742003 | lifeskim:mentions | umls-concept:C0596235 | lld:lifeskim |
pubmed-article:11742003 | lifeskim:mentions | umls-concept:C0439799 | lld:lifeskim |
pubmed-article:11742003 | lifeskim:mentions | umls-concept:C0686907 | lld:lifeskim |
pubmed-article:11742003 | pubmed:issue | 9 | lld:pubmed |
pubmed-article:11742003 | pubmed:dateCreated | 2002-2-25 | lld:pubmed |
pubmed-article:11742003 | pubmed:abstractText | We have investigated the functional consequences of three P/Q-type Ca(2+) channel alpha1A (Ca(v)2.1alpha(1)) subunit mutations associated with different forms of ataxia (episodic ataxia type 2 (EA-2), R1279Stop, AY1593/1594D; progressive ataxia (PA), G293R). Mutations were introduced into human alpha1A cDNA and heterologously expressed in Xenopus oocytes or tsA-201 cells (with alpha(2)delta and beta1a) for electrophysiological and biochemical analysis. G293R reduced current density in both expression systems without changing single channel conductance. R1279Stop and AY1593/1594D protein were expressed in tsA-201 cells but failed to yield inward barium currents (I(Ba)). However, AY1593/1594D mediated I(Ba) when expressed in oocytes. G293R and AY1593/1594D shifted the current-voltage relationship to more positive potentials and enhanced inactivation during depolarizing pulses (3 s) and pulse trains (100 ms, 1 Hz). Mutation AY1593/1594D also slowed recovery from inactivation. Single channel recordings revealed a change in fast channel gating for G293R evident as a decrease in the mean open time. Our data support the hypothesis that a pronounced loss of P/Q-type Ca(2+) channel function underlies the pathophysiology of EA-2 and PA. In contrast to other EA-2 mutations, AY1593/1594D and G293R form at least partially functional channels. | lld:pubmed |
pubmed-article:11742003 | pubmed:language | eng | lld:pubmed |
pubmed-article:11742003 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11742003 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11742003 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11742003 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11742003 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11742003 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11742003 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11742003 | pubmed:month | Mar | lld:pubmed |
pubmed-article:11742003 | pubmed:issn | 0021-9258 | lld:pubmed |
pubmed-article:11742003 | pubmed:author | pubmed-author:GroschnerKlau... | lld:pubmed |
pubmed-article:11742003 | pubmed:author | pubmed-author:WapplEdwinE | lld:pubmed |
pubmed-article:11742003 | pubmed:author | pubmed-author:KoschakAlexan... | lld:pubmed |
pubmed-article:11742003 | pubmed:author | pubmed-author:PoteserMichae... | lld:pubmed |
pubmed-article:11742003 | pubmed:author | pubmed-author:SinneggerMart... | lld:pubmed |
pubmed-article:11742003 | pubmed:author | pubmed-author:WalterDorisD | lld:pubmed |
pubmed-article:11742003 | pubmed:author | pubmed-author:EberhartAndre... | lld:pubmed |
pubmed-article:11742003 | pubmed:author | pubmed-author:GlossmannHart... | lld:pubmed |
pubmed-article:11742003 | pubmed:author | pubmed-author:KrausRichard... | lld:pubmed |
pubmed-article:11742003 | pubmed:author | pubmed-author:GrabnerManfre... | lld:pubmed |
pubmed-article:11742003 | pubmed:author | pubmed-author:StriessnigJör... | lld:pubmed |
pubmed-article:11742003 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11742003 | pubmed:day | 1 | lld:pubmed |
pubmed-article:11742003 | pubmed:volume | 277 | lld:pubmed |
pubmed-article:11742003 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11742003 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11742003 | pubmed:pagination | 6960-6 | lld:pubmed |
pubmed-article:11742003 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:meshHeading | pubmed-meshheading:11742003... | lld:pubmed |
pubmed-article:11742003 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:11742003 | pubmed:articleTitle | Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. | lld:pubmed |
pubmed-article:11742003 | pubmed:affiliation | Institut für Biochemische Pharmakologie, Abteilung Pharmakologie und Toxikologie, Institut für Pharmazie, Universität Innsbruck, Peter-Mayrstrasse 1, A-6020 Innsbruck, Austria. | lld:pubmed |
pubmed-article:11742003 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11742003 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:773 | entrezgene:pubmed | pubmed-article:11742003 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:11742003 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11742003 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11742003 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11742003 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11742003 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11742003 | lld:pubmed |